Tagged with Switzerland

Katharina Gasser – Managing Director, Biogen Switzerland & Chair of the Executive Committee, Interpharma (October 2020)
Urs Vögeli – Managing Director, Janssen Switzerland
Why Switzerland Needs a US FTA to Stop it ‘Falling Through the Cracks’
Market Access in Switzerland: Reimbursement Delays for 76% of New Products Undermining Innovation Reputation
Stephan Mumenthaler – Director General, scienceindustries, Switzerland
Axel Steiger – CEO, Bayer Switzerland
René P Buholzer – CEO, Interpharma, Switzerland (September 2020)
Martin Naville – CEO, Swiss-American Chamber of Commerce
Switzerland Innovation & Competitiveness Snapshot 2020
Roche: Back on Top of The Global Biopharma Rankings
Merck’s EUR 250 Million Investment in New Swiss Biotech Facility
Peter Harradine – President, Swiss Business Council Dubai and Northern Emirates
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here